{"transactions":[{"id":740151,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":38824,"kind":"person","name":"Wallace Max N.","position":1,"cik":"0001877453","reported_name":"Wallace Max N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-06-12T17:58:46.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on June 11, 2027, after which 1/48 of the option will become exercisable on the 11th of each month through June 11, 2030."}],"balance_after":80000,"derivative":{"exercise_price":1.08,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001104659-26-073616","document":"tm2617880-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877453/000110465926073616/tm2617880-9_4seq1.xml","form_type":"4"}},{"id":1109969,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":38824,"kind":"person","name":"Wallace Max N.","position":1,"cik":"0001877453","reported_name":"Wallace Max N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-06-16T16:32:08.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029."}],"balance_after":80000,"derivative":{"exercise_price":2.41,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001818382-25-000115","document":"wk-form4_1750105920.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877453/000181838225000115/wk-form4_1750105920.xml","form_type":"4"}},{"id":1477495,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":38824,"kind":"person","name":"Wallace Max N.","position":1,"cik":"0001877453","reported_name":"Wallace Max N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2024-06-17T16:12:43.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on June 13, 2025, after which 1/48 of the option will become exercisable on the 13th of each month through June 13, 2028."}],"balance_after":50000,"derivative":{"exercise_price":7.2,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001818382-24-000141","document":"wk-form4_1718655156.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877453/000181838224000141/wk-form4_1718655156.xml","form_type":"4"}},{"id":1507337,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":38824,"kind":"person","name":"Wallace Max N.","position":1,"cik":"0001877453","reported_name":"Wallace Max N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-21T16:08:57.000Z","date":"2024-05-20","kind":"purchase","planned":false,"acquired":true,"shares":3990,"price":6.29,"value":25097.1,"ownership":{"direct":false,"nature":"Max N Wallace IRA"},"balance_after":3990,"source":{"system":"sec-edgar","filing":"0001818382-24-000067","document":"wk-form4_1716322124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877453/000181838224000067/wk-form4_1716322124.xml","form_type":"4"}},{"id":1507336,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":38824,"kind":"person","name":"Wallace Max N.","position":1,"cik":"0001877453","reported_name":"Wallace Max N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-21T16:08:57.000Z","date":"2024-05-20","kind":"purchase","planned":false,"acquired":true,"shares":4015,"price":6.21,"value":24933.15,"ownership":{"direct":false,"nature":"Max Wallace SEP IRA"},"balance_after":4015,"source":{"system":"sec-edgar","filing":"0001818382-24-000067","document":"wk-form4_1716322124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877453/000181838224000067/wk-form4_1716322124.xml","form_type":"4"}},{"id":1732962,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":38824,"kind":"person","name":"Wallace Max N.","position":1,"cik":"0001877453","reported_name":"Wallace Max N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2023-11-21T16:07:39.000Z","date":"2023-11-21","kind":"exercise","planned":false,"acquired":false,"shares":6564,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.19,"exercise_date":"2016-11-22","expiration_date":"2023-11-22","underlying":"Common Stock","underlying_shares":6564},"source":{"system":"sec-edgar","filing":"0001818382-23-000165","document":"wk-form4_1700600845.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877453/000181838223000165/wk-form4_1700600845.xml","form_type":"4"}},{"id":1732961,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":38824,"kind":"person","name":"Wallace Max N.","position":1,"cik":"0001877453","reported_name":"Wallace Max N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-21T16:07:39.000Z","date":"2023-11-21","kind":"exercise","planned":false,"acquired":true,"shares":6564,"price":1.19,"value":7811.16,"ownership":{"direct":true},"balance_after":56550,"source":{"system":"sec-edgar","filing":"0001818382-23-000165","document":"wk-form4_1700600845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877453/000181838223000165/wk-form4_1700600845.xml","form_type":"4"}},{"id":1852669,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":38824,"kind":"person","name":"Wallace Max N.","position":1,"cik":"0001877453","reported_name":"Wallace Max N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2023-06-16T16:13:07.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on June 15, 2024, after which 1/48 of the option will become exercisable on the 15th of each month through June 15, 2027."}],"balance_after":8500,"derivative":{"exercise_price":3.35,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001818382-23-000094","document":"wf-form4_168694637062084.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877453/000181838223000094/wf-form4_168694637062084.xml","form_type":"4"}},{"id":2234407,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":38824,"kind":"person","name":"Wallace Max N.","position":1,"cik":"0001877453","reported_name":"Wallace Max N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-06-13T16:22:29.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026."}],"balance_after":8500,"derivative":{"exercise_price":4.34,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001818382-22-000093","document":"wf-form4_165515173318572.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877453/000181838222000093/wf-form4_165515173318572.xml","form_type":"4"}},{"id":2541815,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":38824,"kind":"person","name":"Wallace Max N.","position":1,"cik":"0001877453","reported_name":"Wallace Max N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2021-10-15T15:31:25.000Z","date":"2021-10-13","kind":"grant","acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on October 13, 2022, after which 1/36 of the option will become exercisable on the 13th of each month through October 13, 2025."}],"balance_after":8500,"derivative":{"exercise_price":10.03,"expiration_date":"2031-10-13","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001104659-21-126701","document":"tm2130120-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877453/000110465921126701/tm2130120-10_4seq1.xml","form_type":"4"}},{"id":2588541,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":38824,"kind":"person","name":"Wallace Max N.","position":1,"cik":"0001877453","reported_name":"Wallace Max N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2021-08-27T16:10:40.000Z","date":"2021-08-26","kind":"grant","acquired":true,"shares":17068,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As part of the Business Combination, each Legacy Humacyte stock option was exchanged for a stock option to acquire 0.2626 shares of common stock of Humacyte, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options are fully vested and exercisable."}],"balance_after":17068,"derivative":{"exercise_price":6.54,"expiration_date":"2028-04-12","underlying":"Common Stock","underlying_shares":17068},"source":{"system":"sec-edgar","filing":"0001104659-21-110531","document":"tm2125954-19_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1877453/000110465921110531/tm2125954-19_4seq1.xml","form_type":"4"}},{"id":2588540,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":38824,"kind":"person","name":"Wallace Max N.","position":1,"cik":"0001877453","reported_name":"Wallace Max N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2021-08-27T16:10:40.000Z","date":"2021-08-26","kind":"grant","acquired":true,"shares":13129,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As part of the Business Combination, each Legacy Humacyte stock option was exchanged for a stock option to acquire 0.2626 shares of common stock of Humacyte, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options are fully vested and exercisable."}],"balance_after":13129,"derivative":{"exercise_price":2.56,"expiration_date":"2025-09-01","underlying":"Common Stock","underlying_shares":13129},"source":{"system":"sec-edgar","filing":"0001104659-21-110531","document":"tm2125954-19_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1877453/000110465921110531/tm2125954-19_4seq1.xml","form_type":"4"}},{"id":2588539,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":38824,"kind":"person","name":"Wallace Max N.","position":1,"cik":"0001877453","reported_name":"Wallace Max N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2021-08-27T16:10:40.000Z","date":"2021-08-26","kind":"grant","acquired":true,"shares":6564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As part of the Business Combination, each Legacy Humacyte stock option was exchanged for a stock option to acquire 0.2626 shares of common stock of Humacyte, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options are fully vested and exercisable."}],"balance_after":6564,"derivative":{"exercise_price":1.19,"expiration_date":"2023-11-22","underlying":"Common Stock","underlying_shares":6564},"source":{"system":"sec-edgar","filing":"0001104659-21-110531","document":"tm2125954-19_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877453/000110465921110531/tm2125954-19_4seq1.xml","form_type":"4"}},{"id":2588538,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":38824,"kind":"person","name":"Wallace Max N.","position":1,"cik":"0001877453","reported_name":"Wallace Max N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-27T16:10:40.000Z","date":"2021-08-26","kind":"grant","acquired":true,"shares":49986,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 26, 2021, Alpha Healthcare Acquisition Corp. (\"AHAC\") consummated a business combination (the \"Business Combination\") by and among AHAC, Hunter Merger Sub, Inc., a Delaware corporation (\"Hunter Merger Sub\") and Humacyte, Inc., a Delaware corporation (\"Legacy Humacyte\"), AHAC changed its name to \"Humacyte, Inc.\" and Hunter Merger Sub merged with and into Legacy Humacyte. As part of the Business Combination, each share of Legacy Humacyte stock was exchanged for 0.2626 shares of common stock of Humacyte, Inc."}],"balance_after":49986,"source":{"system":"sec-edgar","filing":"0001104659-21-110531","document":"tm2125954-19_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877453/000110465921110531/tm2125954-19_4seq1.xml","form_type":"4"}}]}